These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3902166)

  • 21. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; LeMaistre CF; Spinolo J; Spitzer G; Yau J; Dicke K; Jagannath S; Deisseroth AB
    Cancer; 1991 Jun; 67(12):2959-65. PubMed ID: 1675151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
    Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome changes and splenectomy in Ph1-positive CML. II. Prognostic aspects in the blastic phase.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1984 Aug; 12(4):303-8. PubMed ID: 6589034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic value of the terminal deoxynucleotidyl transferase (TdT) activity in treating the blastic phase (bp) of chronic granulocytic leukaemia (CGL).
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M; Duraj M; Jarczok K; Hołowiecka B; Suhs M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):864-71. PubMed ID: 2419215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
    Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marrow transplantation for the treatment of chronic myelogenous leukemia.
    Thomas ED; Clift RA; Fefer A; Appelbaum FR; Beatty P; Bensinger WI; Buckner CD; Cheever MA; Deeg HJ; Doney K
    Ann Intern Med; 1986 Feb; 104(2):155-63. PubMed ID: 3511810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases.
    Lemonnier MP; Gorin NC; Laporte JP; Douay L; Lopez M; van den Akker J; Stachowiak J; David R; Pene F; Kantor G
    Exp Hematol; 1986 Aug; 14(7):654-8. PubMed ID: 3525203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
    Raanani P; Trakhtenbrot L; Rechavi G; Rosenthal E; Avigdor A; Brok-Simoni F; Leiba M; Amariglio N; Nagler A; Ben-Bassat I
    Acta Haematol; 2005; 113(3):181-9. PubMed ID: 15870488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
    Román J; Alvarez MA; Torres A
    Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible association of a new translocation, t(7;11)(p15;p15), with Ph1 chromosome-negative chronic myelogenous leukemia.
    Kaneko Y; Maseki N; Takasaki N; Sakurai M; Kawai K; Sakurai M
    Int J Cancer; 1985 Dec; 36(6):657-9. PubMed ID: 3864754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of the blastic crisis cell clone in chronic myeloid leukaemia.
    Löwenberg B; Hagemeijer A; Abels J
    Br J Haematol; 1985 Jan; 59(1):27-36. PubMed ID: 3855648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
    Kantarjian HM; Smith TL; McCredie KB; Keating MJ; Walters RS; Talpaz M; Hester JP; Bligham G; Gehan E; Freireich EJ
    Blood; 1985 Dec; 66(6):1326-35. PubMed ID: 3864497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation.
    Chiba A; Toya T; Mizuno H; Tokushige J; Nakamura F; Nakazaki K; Kurokawa M
    Int J Hematol; 2018 Dec; 108(6):640-646. PubMed ID: 30078165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
    McGlave PB; Arthur D; Miller WJ; Lasky L; Kersey J
    Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adult form of chronic myelogenous leukemia in childhood--a retrospective analysis of 20 patients].
    Creutzig U; Brandeis W; Gerein V; Ritter J; Stollmann B; Kabisch H; Niethammer D; Schellong G
    Klin Padiatr; 1985; 197(3):203-6. PubMed ID: 3859702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Shi HL; Lu Y; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):158-62. PubMed ID: 15182585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
    Kimby E; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.
    Nesbit ME; Buckley JD; Feig SA; Anderson JR; Lampkin B; Bernstein ID; Kim TH; Piomelli S; Kersey JH; Coccia PF
    J Clin Oncol; 1994 Jan; 12(1):127-35. PubMed ID: 8270968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.